Clinical benefit with PEMAZYRE — 3 of 3

Responses with PEMAZYRE are durable

Durable benefits were observed with PEMAZYRE (N=108), with a median duration of response of 8.1 months1

Median DOR was 8.1 months
(95% CI, 5.65–13.14)1*

8.1

Months

*95% CI was calculated using the Brookmeyer and Crowley method.1

66.0%

(95% CI, 48.0–79.1)

Patients with response maintained at
6 months (KM estimate)1

47.6%

(95% CI, 30.2–63.1)

Patients with response maintained at
9 months (KM estimate)1

37.5%

(95% CI, 21.3–53.7)

Patients with response maintained at
12 months (KM estimate)1

For further efficacy information, please refer to the PEMAZYRE Swissmedic Professional Information.1